Comparison of three methods for testing azole susceptibilities of Candida albicans strains isolated sequentially from oral cavities of AIDS patients

Journal of Clinical Microbiology

Volumn 36, Issue 6, 1998, Pages 1578-1583

  Tortorano, Anna Maria ^a   Viviani, Maria Anna ^a   Barchiesi, Francesco ^b   Arzeni, Daniela ^b   Rigoni, Anna Lisa ^a   Cogliati, Massimo ^a   Compagnucci, Patrizia ^b   Scalise, Giorgio ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; PYRROLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; REFERENCE VALUE;

CANDIDA ALBICANS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0031958128     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.6.1578-1583.1998     Document Type: Article

References (28)

1. Barchiesi, F., A. L. Colombo, D. A. McGough, A. W. Fothergill, and M. G. Rinaldi. 1994. In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 38: 1530-1533.
2. Barchiesi, F., R. J. Hollis, D. A. McGough, G. Scalise, M. G. Rinaldi, and M. A. Pfaller. 1995. DNA subtypes and fluconazole susceptibilities of Candida albicans from the oral cavities of patients with AIDS. Clin. Infect. Dis. 20:634-640.
3. Bland, J. M., and D. G. Altman. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i:307-311.
4. Colombo, A. L., F. Barchiesi, D. A. McGough, and M. G. Rinaldi. 1995. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing. J. Clin. Microbiol. 33:535-540.
5. Cook, R. A., K. A. McIntyre, and J. N. Galgiani. 1990. Effects of incubation temperature, inoculum size, and medium on agreement of macro- and microdilution broth susceptibility test results for yeasts. Antimicroh. Agents Chemother. 34:1542-1545.
6. Drouhet, E., B. Dupont, L. Improvisi, M. A. Viviani, and A. M. Tortorano. 1986. Disc agar diffusion and microplate automatized technics for in vitro evaluation of antifungal agents on yeasts and sporulated pathogenic fungi, p. 31-49. In K. Iwata and H. Vanden Bossche (ed.), In vitro and in vivo evaluation of antifungal agents. Elsevier Science Publishers B.V. Amsterdam, The Netherlands.
7. Druetta, A., A. Freydiere, R. Guinet, and Y. Gille. 1993. Evaluation of five commercial antifungal susceptibility testing systems. Eur. J. Clin. Microbiol. Infect. Dis. 12:336-342.
8. Dupont, B., L. Improvisi, M. Eliaszewicz, G. Pialoux, and the GEMO. 1992. Resistance of Candida albicans to fluconazole in AIDS patients, abstr. 1203, p. 311. In Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
9. Espinel-Ingroff, A., M. Pfaller, M. E. Erwin, and R. N. Jones. 1996. An interlaboratory evaluation of Etest method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using Casitone agar and solidified RPMI 1640 medium with 2% glucose. J. Clin. Microbiol. 34:848-852.
10. Galgiani, J. N. 1987. Antifungal susceptibility tests. Antimicrob. Agents Chemother. 31:1867-1870.
11. He, X., R. N. Tiballi, L. T. Zarins, S. F. Bradley, J. A. Sangeorzan, and C. A. Kauffman. 1994. Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 38:2495-2497.
12. Johnson, E. M., D. W. Warnock, J. Luker, S. R. Porter, and C. Scully. 1995. Emergence of azole resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. J. Antimicrob. Chemother. 35:103-114.
13. National Committee for Clinical Laboratory Standards. 1995. Reference method for broth dilution antifungal susceptibility testing of yeasts. Tentative standard M27-T. National Committee for Clinical Laboratory Standards, Villanova, Pa.
14. Pfaller, M. A., B. Buschelman, M. J. Bale, M. Lancaster, A. Espinel-Ingroff, J. H. Rex, and M. G. Rinaldi. 1994. Multicenter comparison of a colorimetric microdilution broth method with the reference macrodilution method for in vitro susceptibility testing of yeast isolates. Diagn. Microbiol. Infect. Dis. 19:9-13.
15. Pfaller, M. A., C. Grant, V. Mortland, and J. Rhine-Chalberg. 1994. Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans. J Clin. Microbiol. 32:506-509.
16. Pfaller, M. A., and M. G. Rinaldi. 1993. Antifungal susceptibility testing. Current state of technology, limitations, and standardization. Infect. Dis. Clin. N. Am. 7:435-444.
17. Redding, S., J. Smith, G. Farinacci, M. G. Rinaldi, A. Fothergill, J. Rhine-Chalberg, and M. Pfaller. 1994. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation of in vitro susceptibility testing and DNA subtype analysis. Clin. Infect. Dis. 18:240-242.
18. Rex, J. H., M. A. Pfaller, M. G. Rinaldi, A. Polak, and J. N. Galgiani. 1993. Antifungal susceptibility testing. Clin. Microbiol. Rev. 6:367-381.
19. Rex, J. H., M. G. Rinaldi, and M. A. Pfaller. 1995. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39:1-8.
20. Ruhnke, M., A. Eigler, E. Engelmann, B. Geiseler, and M. Trautmann. 1994. Correlation between antifungal susceptibility testing of Candida isolates from patients with HIV infection and clinical results after treatment with fluconazole. Infection 22:132-136.
21. Ruhnke, M., A. Schmidt-Westhausen, E. Engelmann, and M. Trautmann. 1996. Comparative evaluation of three antifungal susceptibility test methods for Candida albicans isolates and correlation with response to fluconazole therapy. J. Clin. Microbiol. 34:3208-3211.
22. Sanchez, M. L., and R. N. Jones. 1992. Etest, an antimicrobial susceptibility testing method with broad clinical and epidemiologic application. Antimicrob. Newsl. 8:1-7.
23. Schmalreck, A. F., et al. 1996. Empfindlichkeitsprufung von Fluconazole: Auswertung einer Multizenter-Studie der Arbeitsgemeinschaft "Klinische Mykologie" der deutschsprachigen mykologischen Gesellschaft. Mycoses 39(Suppl. 2):1-11.
24. Sewell, D. L., M. A. Pfaller, and A. L. Barry. 1994. Comparison of broth macrodilution, broth microdilution, and E test antifungal susceptibility tests for fluconazole. J. Clin. Microbiol. 32:2099-2102.
25. Sheehan, D. J., A. Espinel-Ingroff, L. S. Moore, and C. D. Webb. 1993. Antifungal susceptibility testing of yeasts: a brief overview. Clin. Infect. Dis. 17(Suppl. 2):S494-S500.
26. Viviani, M. A., A. M. Tortorano, E. Cabrini, and A. Restelli. 1980. Effetto del terreno di coltura sull'attività in vitro di tre derivati dell'imidazolo: miconazolo, econazolo, ketoconazolo. Chemioter. Antimicrob. 3:129-134.
27. Warren, N. G., and H. J. Shadomy. 1991. Yeasts of medical importance, p. 617-629. In A. Balows, W. J. Hausler, Jr., K. L. Herrmann, H. D. Isenberg, and H. J. Shadomy (ed.), Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
28. Werner, E., M. Seilbold, and E. Antweiler. 1993. Susceptibility testing of Candida species for fluconazole: the role of buffering in the agar dilution assay. Mycoses 36:125-130.